Influence of Different Parameters on Extubation Time After Cardiac Surgery.

January 23, 2020 updated by: Eric DEFLANDRE, MD, PhD, FCCP, FAHA, Astes
The aim of this study is to determine which factors could be at risk of delayed extubation after cardiac surgery.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The aim of this study is to determine which factors could be at risk of delayed extubation after cardiac surgery. Several parameters of ventilation and infusion were recorded during surgery. A statistical analysis will be performed to determine if one of many of these are significant. The investigator does not assign specific interventions to the study participants, so the present study is observational and not interventional.

Study Type

Observational

Enrollment (Actual)

132

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Belgium
    • Namur
      • Bouge, Namur, Belgium, 5004
        • Clinique Saint-Luc de Bouge

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All patients scheduled for cardiac surgery in the Saint-Luc Bouge hospital.

Description

Inclusion Criteria:

  • All patients for elective cardiac surgery

Exclusion Criteria:

  • Emergency procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patient at risk for OSA scheduled for Cardiac surgery
Patients with a positive STOP-Bang and DES-OSA score (that means patients at risk for OSA)
Other: Duration of intubation
Time between intubation in the operating room and exhumation in the Intensive Care Unit.
Diagnostic test: Evolution of the renal function
Evolution of the renal function in the next two days
Patient not at risk for OSA scheduled for Cardiac surgery
Patients with a negative STOP-Bang and DES-OSA score (that means patients not at risk for OSA)
Other: Duration of intubation
Time between intubation in the operating room and exhumation in the Intensive Care Unit.
Diagnostic test: Evolution of the renal function
Evolution of the renal function in the next two days

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time of extubation
Time Frame: 2 Days
Time when extubation is performed
2 Days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Astes

Investigators

  • Principal Investigator: Eric Deflandre, Astes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 9, 2017

Primary Completion (Actual)

April 3, 2018

Study Completion (Actual)

June 1, 2018

Study Registration Dates

First Submitted

October 9, 2017

First Submitted That Met QC Criteria

October 12, 2017

First Posted (Actual)

October 13, 2017

Study Record Updates

Last Update Posted (Actual)

January 27, 2020

Last Update Submitted That Met QC Criteria

January 23, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • VACC Study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Thoracic Surgery

Clinical Trials on Duration of intubation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe